Home›Eletriptan

Eletriptan

Also known as: Relpax

2 interactions on record

Eletriptan has 2 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Deferasirox, Paclitaxel. Patients taking Eletriptan should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 2
Moderate: 2

Moderate (2)

Eletriptan + Deferasirox— Deferasirox may induce CYP3A4 resulting in decreased eletriptan concentration. Monitor for reduced effectiveness.
Eletriptan + Paclitaxel— CYP3A4 substrate; caution should be exercised when administering paclitaxel concomitantly.

Eletriptan + Deferasirox🟡Moderate

Deferasirox may induce CYP3A4 resulting in decreased eletriptan concentration. Monitor for reduced effectiveness.

Eletriptan + Paclitaxel🟡Moderate

CYP3A4 substrate; caution should be exercised when administering paclitaxel concomitantly.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.